SYSTEMATIC REVIEW OF REPRODUCTIVE OUTCOMES FOR WOMEN UNDERGOING FERTILITY-SPARING THERAPY WITH PROGESTIN AND METFORMIN FOR ATYPICAL ENDOMETRIAL HYPERPLASIA AND EARLY ENDOMETRIAL CANCER.

被引：0
|
作者：
Chae-Kim, Jennifer [1 ]
Garg, Gunjal [1 ]
Gavrilova-Jordan, Larisa [2 ]
Blake, Lindsay E. [3 ]
Kim, Tongil T. I. [4 ]
Hayslip, Clifford Cal, Jr. [1 ]
机构：
[1] East Carolina Univ, Greenville, NC 27858 USA
[2] Augusta Univ, Med Coll Georgia, Augusta, GA USA
[3] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[4] Emory Univ, Goizueta Business Sch, Atlanta, GA 30322 USA
来源：
FERTILITY AND STERILITY | 2020年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-51
引用
下载
收藏
页码：E21 / E22
页数：2
相关论文
共 50 条
  • [31] Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis
    Koskas, Martin
    Uzan, Jennifer
    Luton, Dominique
    Rouzier, Roman
    Darai, Emile
    FERTILITY AND STERILITY, 2014, 101 (03) : 785 - +
  • [32] Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia A meta-analysis and systematic review
    Wei, Jing
    Zhang, Weiyuan
    Feng, Limin
    Gao, Wanli
    MEDICINE, 2017, 96 (37)
  • [33] Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer
    Park, Jeong-Yeol
    Seong, Seok Ju
    Kim, Tae-Jin
    Kim, Jae Weon
    Bae, Duk-Soo
    Nam, Joo-Hyun
    GYNECOLOGIC ONCOLOGY, 2017, 146 (01) : 39 - 43
  • [34] PROGNOSTIC FACTORS OF ONCOLOGIC AND REPRODUCTIVE OUTCOMES IN FERTILITY-SPARING TREATMENT OF COMPLEX ATYPICAL HYPERPLASIA AND LOW GRADE ENDOMETRIAL CANCER USING ORAL PROGESTIN IN CHINESE PEOPLE
    Zhou, R.
    Lu, Q.
    Wang, J.
    Wang, S.
    Zhu, H.
    Wang, Z.
    Miao, Y.
    Wei, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1361 - 1362
  • [35] Fertility-sparing treatment in women with endometrial cancer
    Won, Seyeon
    Kim, Mi Kyoung
    Seong, Seok Ju
    CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM, 2020, 47 (04): : 237 - 244
  • [36] METFORMIN MAY ATTENUATE THE EFFECT OF HYPERPROLACTINEMIA DURING THE FERTILITY-SPARING TREATMENT MEDROXYPROGESTERONE-ACETATE FOR ATYPICAL ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL CANCER
    Habu, Y.
    Mitsuhashi, A.
    Kobayashi, T.
    Gu, W.
    Matsuoka, A.
    Hanawa, S.
    Nishikimi, K.
    Tate, S.
    Usui, H.
    Shozu, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1079 - 1079
  • [37] Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions
    Contreras, Nayanar-Adela
    Sabadell, Jordi
    Verdaguer, Paula
    Julia, Carla
    Fernandez-Montoli, Maria-Eulalia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [38] Oncologic, fertility, and obstetric outcomes with MPA therapy in women with endometrial cancer and atypical endometrial hyperplasia
    Takeda, Asuka
    Yamamoto, Yuri
    Tamura, Kou
    Aoki, Hidenori
    Noguchi, Hiroki
    Minato, Saki
    Kamada, Shuhei
    Arakaki, Ryosuke
    Kaji, Takashi
    Iwasa, Takeshi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2024, 50 (04) : 633 - 638
  • [39] Fertility outcomes with assisted reproductive technology after fertility-sparing treatment for endometrial neoplasia: a systematic review
    Manguso, Elizabeth
    Thayer, Elizabeth G.
    Starbuck, Kristen D.
    Marsidi, Audrey
    F&S REVIEWS, 2023, 4 (04): : 207 - 218
  • [40] EFFECT OF MEGESTROL ACETATE PLUS METFORMIN AS FERTILITY-SPARING TREATMENT FOR PATIENTS WITH ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CANCER. A RANDOMIZED CONTROLLED TRIAL
    Yang, B.
    Yierfulati, G.
    Guan, J.
    Chen, X.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A4 - A5
12345